Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as one of the most effective medications for weight reduction, with clinical trials showing average weight loss of 10-15% of body weight over 68 weeks
Never skip sunscreen after applying Vitamin C in the morning
Without available food and the need to sustain energy, the body decreases insulin levels and releases glucagon hormone
No heterogeneity of the glycaemic response was observed according to age ( 65 years), diabetes duration ( 10 years), BMI ( 30 kg/m 2 ), presence of CKD stage III or higher, microangiopathy, macroangiopathy, or concomitant treatment with SGLT-2 inhibitors (Fig
packing: 473ml.
This approval for Ozempic allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of adults and could have serious consequences if left untreated. January 27, 2026- A federal court judge in Washington denied a motion to throw out Novo Nordisks ozempic lawsuit which alleged that a telehealth platform named Invigor engaged in false medical advertising concerning ozempic alternatives
